# Aardvark Therapeutics, Inc.: Form 8-K, filed May 7, 2026

- Company: [Aardvark Therapeutics, Inc.](/companies/aard.md) (CIK 1774857)
- Form: 8-K
- Filed: 2026-05-07
- Accepted by EDGAR: May 7, 2026, 09:28 ET
- Period: 2026-05-07
- Accession: 0001193125-26-210664
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1774857/000119312526210664/ck0001774857-20260507.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1774857/000119312526210664/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1774857/000119312526210664/ck0001774857-20260507.htm

Filed May 7, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-210664. Last ingested by Listed: Nov 11, 2026, 03:29 ET. No prices; not investment advice.